Xtant Medical Holdings's EBIT per Share for the
three
months ended in Mar. 2024 was $-0.03.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 was $-0.00.
During the past 3 years, the average EBIT per Share Growth Rate was -45.40% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 29.70% per year.
During the past 10 years, the average EBIT per Share Growth Rate was 51.20% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Xtant Medical Holdings's EBIT per Share or its related term are showing as below:
XTNT'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -45.4 Med: 21.65 Max: 85.8
Current: -45.4
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Xtant Medical Holdings was 85.80% per year. The lowest was -45.40% per year. And the median was 21.65% per year.
XTNT's 3-Year EBIT Growth Rate is ranked worse than 91.08% of 729
companies
in the Medical Devices & Instruments industry
Industry Median: 5.8
vs XTNT: -45.40
Xtant Medical Holdings EBIT per Share Historical Data
The historical data trend for Xtant Medical Holdings's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.00
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Xtant Medical Holdings (AMEX:XTNT) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Xtant Medical Holdings EBIT per Share Related Terms
Thank you for viewing the detailed overview of Xtant Medical Holdings's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Xtant Medical Holdings (Xtant Medical Holdings) Business Description
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the US.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XTNT has been successfully added to your 